What the Smartest Investors Know About Moderna Stock
It wasn't all that long ago that Moderna (NASDAQ: MRNA) ranked among the hottest stocks on the market. The company emerged as one of the top winners in the race to develop COVID-19 vaccines. Moderna's shares skyrocketed 2,500% from its initial public offering in December 2018 through July 2021.
But the story has been much different for Moderna since then. The glow from the early COVID-19 vaccine success quickly faded. What's next for the beaten-down vaccine stock? Here's what the smartest investors know about Moderna stock.
Moderna's share price has been highly volatile so far this year. This isn't likely to change anytime soon for a simple reason: Significant uncertainty remains about the demand for COVID-19 vaccines. As a result, there's also significant uncertainty about Moderna's financial performance over the next few years.
Source Fool.com
